Originally published on the Canadian Antimicrobial Innovation Coalition (CAIC) website. To mark World Antimicrobial Awareness Week,...

Public awareness is growing in Canada and around the world about the urgent need for concerted global action to counter the serious...

EDMONTON, Alberta – Fedora Pharmaceuticals, Inc. announced they have received nonrefundable financial contribution from the National...

Originally published on the National Research Council of Canada. EDMONTON, Alberta - Doctors around the world are starting to speak with...

Originally published on the Review on Antimicrobial Resistance. Antimicrobials, and specifically antibiotics, play a crucial role in...

EDMONTON, Alberta - Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award EDMONTON, Alberta – November 30,...

EDMONTON, Alberta – November 9, 2015 – Fedora Pharmaceuticals Inc., a biotechnology company headquartered in Edmonton, Alberta, Canada,...

Originally published on Roche.com BASEL, Switzerland - Roche (SIX: RO, ROG; OTCQX: RHHBY), Meiji Seika Pharma (Meiji) and Fedora...

Findings Presented at Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) EDMONTON, Alberta – September 12, 2013 –...

EDMONTON, Alberta – October 31, 2012 – Fedora Pharmaceuticals, Inc. today announced the creation of a Board of Directors and appointment...

EDMONTON, Alberta – September 5, 2012 – Fedora Pharmaceuticals, Inc. today announced the appointment of Thomas Parr, Ph.D. to the newly...